Jefferies Financial Group Inc. Sells 262,420 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Jefferies Financial Group Inc. cut its stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 99.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,580 shares of the biotechnology company's stock after selling 262,420 shares during the quarter. Jefferies Financial Group Inc.'s holdings in Axon Enterprise were worth $1,533,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. New Wave Wealth Advisors LLC bought a new position in Axon Enterprise during the fourth quarter worth about $40,000. Y.D. More Investments Ltd bought a new position in Axon Enterprise during the fourth quarter worth about $45,000. Stonebridge Financial Group LLC bought a new position in Axon Enterprise during the fourth quarter worth about $53,000. GPS Wealth Strategies Group LLC increased its position in Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after acquiring an additional 40 shares during the period. Finally, Berbice Capital Management LLC bought a new position in Axon Enterprise during the fourth quarter worth about $59,000. 79.08% of the stock is owned by institutional investors.

Insider Activity

In other news, President Joshua Isner sold 9,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $683.31, for a total value of $6,149,790.00. Following the sale, the president now directly owns 308,714 shares in the company, valued at approximately $210,947,363.34. This trade represents a 2.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Patrick W. Smith sold 10,000 shares of the firm's stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 23,764 shares of company stock worth $14,856,635. Corporate insiders own 4.40% of the company's stock.

Axon Enterprise Trading Up 0.5%

AXON opened at $728.53 on Thursday. The company's 50 day moving average is $576.22 and its 200-day moving average is $589.48. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $732.17. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market cap of $56.72 billion, a P/E ratio of 188.25, a PEG ratio of 5.17 and a beta of 1.24.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The company had revenue of $603.63 million for the quarter, compared to the consensus estimate of $585.67 million. During the same period last year, the company posted $1.15 EPS. The firm's quarterly revenue was up 31.3% compared to the same quarter last year. Equities research analysts predict that Axon Enterprise, Inc. will post 5.8 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on AXON shares. Craig Hallum lowered shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. The Goldman Sachs Group raised their target price on shares of Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday. Needham & Company LLC raised their target price on shares of Axon Enterprise from $600.00 to $750.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Finally, JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $652.73.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.